MedTrace Logo

Childhood Cancer Survivors' Affective Response to Exercise

NCT05763290 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2026-04-23

No results posted yet for this study

Summary

The primary objective of this study is to assess the feasibility of administering the Personalized Single-Category Implicit Association Test (PSC-IAT) to young adult survivors of childhood cancer.

Participants will perform a total of three trials of a cognitive task before and after their scheduled SJLIFE cardiovascular stress testing. Participants will then be asked to participate in a qualitative interview about the cognitive task tool and body sensations and emotions experienced during exercise.

Conditions

Interventions

OTHER

Affective Response to Exercise

Participants will perform a total of three trials of a cognitive task before and after their scheduled SJLIFE cardiovascular stress testing. Participants will then be asked to participate in a qualitative interview about the cognitive task tool and body sensations and emotions experienced during exercise.

Sponsors & Collaborators

Principal Investigators

  • Megan Ware, MS, PhD · St. Jude Children's Research Hospital

  • Deo Srivastava, PhD · St. Jude Children's Research Hospital

  • Lisa Jacola, PhD, ABPP-CN2 · St. Jude Children's Research Hospital

  • Rachel Webster, PhD · St. Jude Children's Research Hospital

  • Tara Brinkman, PhD · St. Jude Children's Research Hospital

  • Kevin Krull, PhD · St. Jude Children's Research Hospital

  • Melissa Hudson, MD · St. Jude Children's Research Hospital

  • Leslie Robinson, PhD · St. Jude Children's Research Hospital

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-22
Primary Completion
2027-02-28
Completion
2030-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05763290 on ClinicalTrials.gov